Skip to content

DFDV DFDV Deferred offering costs

Deferred offering costs at other companies

Hitachi logo
HitachiHIT
$170.98K
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$164.72K
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$18.09K-98.8%
DeFi Development Corp. Common Stock logo
DeFi Development Corp. Common StockDFDV
$3.36M+2,861%
ROC
Rank One Computing ROC
$226.8K
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%

Other financials

Income statement

See full
Revenue$2.7M+828%
Gross profit$2.6M+814%
Operating income-$55.2M-6,154%
Net income-$83.4M-10,619%
EPS (diluted)-$3.18-3,875%

Balance sheet

See full
Cash & equivalents$3.7M+104%
Total debt$127.8M+226,535%
Total equity$10.2M+258%
Total assets$229.7M+5,425%

Cash flow

See full
Operating cash flow-$9.8M-1,151%
CapEx$500.0-95.0%
Free cash flow-$10.9M-5,681%

Valuation

See full
Market cap$88.55M-66.5%
Enterprise value$212.64M-25.1%
P/S6.4×-68.6×

Profitability

See full
Gross margin97.5%-0.9pp
Operating margin-659.3%-919pp
Net margin-1,136.4%-1,303pp
FCF margin-116.2%+98.4pp

Returns & leverage

See full
Return on equity-2,398.4%-2,467pp
Debt / equity12.5×+12.5×
Current ratio1.4×-1.5×

Where this comes from

Reported directly by DFDV in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: DFDV’s 10-Q, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about DFDV's deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DFDV's deferred offering costs?
DFDV (DFDV) reported deferred offering costs of $3.36M in Q1 2026.
How has DFDV's deferred offering costs changed year-over-year?
DFDV's deferred offering costs increased by 2860.5% year-over-year, from $113.53K to $3.36M.
What does deferred offering costs mean?
These are costs directly attributable to a proposed or completed equity or debt offering that are capitalized on the balance sheet. These costs are typically reclassified to equity or amortized against debt proceeds once the offering is finalized. Tracking these costs provides insight into the capital-raising activities and the associated transaction expenses incurred by the firm.